This is my guess. If they can show the click chemistry approach works in patients then they have a platform that can be scaled out to any antibody.
- Forums
- ASX - By Stock
- CU6
- CU6 - Media and Industry News
CU6 - Media and Industry News, page-157
-
- There are more pages in this discussion • 234 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
|
|||||
Last
$6.30 |
Change
0.075(1.21%) |
Mkt cap ! $1.981B |
Open | High | Low | Value | Volume |
$6.29 | $6.30 | $6.25 | $2.207M | 350.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 8269 | $6.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.30 | 6049 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 10037 | 6.290 |
16 | 5616 | 6.280 |
6 | 3037 | 6.270 |
8 | 4077 | 6.260 |
4 | 2651 | 6.250 |
Price($) | Vol. | No. |
---|---|---|
6.300 | 3814 | 10 |
6.310 | 4670 | 11 |
6.320 | 22913 | 8 |
6.330 | 20000 | 1 |
6.340 | 2465 | 1 |
Last trade - 12.21pm 15/08/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online